SonaliChaudhuryMD

Clinical Trials

• Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy Start of enrollment: 2007 Oct 01

  Completed

  Phase 2, Phase 3

• Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors Start of enrollment: 2008 May 01

  Unknown status

  Phase 1, Phase 2

• Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601) Start of enrollment: 2008 Aug 01

  Completed

  Phase 2

• Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases Start of enrollment: 2001 Dec 01

  Recruiting

  Phase 1, Phase 2

• Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) Start of enrollment: 2013 Dec 01

  Completed

  Phase 2

• Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia Start of enrollment: 2019 Nov 08

  Recruiting

  Phase 2

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01

  Recruiting

  Roles: Principal Investigator, Contact

• Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy Start of enrollment: 2017 Dec 29

  Recruiting

  Phase 3

  Roles: Contact

• A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases Start of enrollment: 2021 Jul 14

  Recruiting

  Phase 2

  Roles: Contact

• A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001) Start of enrollment: 2022 Jul 12

  Recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) Start of enrollment: 2023 Jan 25

  Recruiting

  Phase 3

  Roles: Contact

• Join now to see all